Maglasang, Ronel T.
HRN: 23-95-35 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/28/2023
MUPIROCIN 2%, 15G (TUBE)
10/28/2023
11/04/2023
TOPICAL
15g
BID
ABI
Checking Final Appropriateness
Indication: ProphylaxisEmpiric Type of Infection: Skin & Soft TissueProphylaxis Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes